Related Experiment Video
Updated: Jun 27, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
MPTP-Treated Zebrafish Recapitulate 'Late-Stage' Parkinson's-like Cognitive Decline
Alim A O Bashirzade1,2, Sergey V Cheresiz1,2, Alisa S Belova1,2
1Scientific Research Institute of Neuroscience and Medicine, 630090 Novosibirsk, Russia.
Abstract:
The zebrafish is a promising model species in biomedical research, including neurotoxicology and neuroactive drug screening. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) evokes degeneration of dopaminergic neurons and is commonly used to model Parkinson's disease (PD) in laboratory animals, including zebrafish. However, cognitive phenotypes in MPTP-evoked experimental PD models remain poorly understood. Here, we established an LD50 (292 mg/kg) for intraperitoneal MPTP administration in adult zebrafish, and report impaired spatial working memory (poorer spontaneous alternation in the Y-maze) in a PD model utilizing fish treated with 200 µg of this agent. In addition to conventional behavioral analyses, we also employed artificial intelligence (AI)-based approaches to independently and without bias characterize MPTP effects on zebrafish behavior during the Y-maze test. These analyses yielded a distinct cluster for 200-μg MPTP (vs. other) groups, suggesting that high-dose MPTP produced distinct, computationally detectable patterns of zebrafish swimming. Collectively, these findings support MPTP treatment in adult zebrafish as a late-stage experimental PD model with overt cognitive phenotypes.
Insights
This study shows that 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in zebrafish impairs spatial working memory, modeling Parkinson's disease (PD) cognitive deficits. AI analysis revealed distinct swimming patterns in MPTP-treated zebrafish.
Area of Science:
- Neuroscience
- Toxicology
- Animal Models
Background:
- Zebrafish are valuable models for neurotoxicology and drug screening.
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is used to model Parkinson's disease (PD) by inducing dopaminergic neuron degeneration.
- Cognitive deficits in MPTP-induced PD models are not well understood.
Purpose of the Study:
- To establish MPTP toxicity parameters in adult zebrafish.
- To investigate cognitive phenotypes in an MPTP-induced zebrafish PD model.
- To utilize artificial intelligence (AI) for unbiased behavioral analysis of MPTP effects.
Main Methods:
- Determined the LD50 for intraperitoneal MPTP administration in adult zebrafish.
- Assessed spatial working memory using the Y-maze test in MPTP-treated zebrafish.
- Applied AI-based pattern recognition to analyze zebrafish swimming behavior during the Y-maze test.
Main Results:
- Established an LD50 of 292 mg/kg for MPTP in adult zebrafish.
- MPTP treatment (200 µg) resulted in impaired spatial working memory, indicated by poorer spontaneous alternation.
- AI analysis identified distinct swimming behavior clusters for MPTP-treated groups, differentiating them from controls.
Conclusions:
- MPTP treatment in adult zebrafish effectively models late-stage Parkinson's disease with observable cognitive impairments.
- AI-driven behavioral analysis provides objective and sensitive detection of MPTP-induced neurological changes.
- This zebrafish model offers a valuable platform for studying PD-related cognitive dysfunction and testing therapeutic interventions.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology